Prazosin, an alpha receptor blocker, effectively treats severe congestive heart failure by improving clinical and hemodynamic measures. This vasodilator medication offers significant benefits without adverse counterregulatory effects after four weeks of treatment.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: